GAITHERSBURG, Md.--(BUSINESS WIRE)--Calibrant Biosystems, a biotechnology company specializing in proteomics, today named Dr. Brian Balgley as its Chief Technology Officer. Dr. Balgley joined Calibrant in 2003, and has led the development of the company’s Gemini drug discovery platform in his previous position as Director of Proteomics.
